Li X - Search Results

1

CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms.

Yu X, Liu W, Wang Z, Wang H, Liu J, Huang C, Zhao T, Wang X, Gao S, Ma Y, Wu L, Li X, Yang S, Hao J. Yu X, et al. Among authors: li x. Cancer Lett. 2021 Oct 28;519:289-303. doi: 10.1016/j.canlet.2021.07.024. Epub 2021 Jul 21. Cancer Lett. 2021. PMID: 34302921

2

Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.

Li X, Zhang Y, Ma W, Fu Q, Liu J, Yin G, Chen P, Dai D, Chen W, Qi L, Yu X, Xu W. Li X, et al. Cancer Immunol Immunother. 2020 Apr;69(4):535-548. doi: 10.1007/s00262-019-02457-y. Epub 2020 Jan 21. Cancer Immunol Immunother. 2020. PMID: 31965268 Free PMC article.

3

Enhanced glucose metabolism mediated by CD147 is associated with ¹⁸ F-FDG PET/CT imaging in lung adenocarcinoma.

Zhang Y, Liu J, Sun Y, Yu X, Wang J, Dai D, Zhu Y, Song X, Zhu L, Li X, Xu W. Zhang Y, et al. Among authors: li x. Thorac Cancer. 2020 May;11(5):1245-1257. doi: 10.1111/1759-7714.13383. Epub 2020 Mar 11. Thorac Cancer. 2020. PMID: 32162491 Free PMC article.

4

MOFs-Derived Fe-N Codoped Carbon Nanoparticles as O₂-Evolving Reactor and ROS Generator for CDT/PDT/PTT Synergistic Treatment of Tumors.

Sui C, Tan R, Chen Y, Yin G, Wang Z, Xu W, Li X. Sui C, et al. Among authors: li x. Bioconjug Chem. 2021 Feb 17;32(2):318-327. doi: 10.1021/acs.bioconjchem.0c00694. Epub 2021 Feb 5. Bioconjug Chem. 2021. PMID: 33543921

5

Prediction of EGFR Mutation Status Based on ¹⁸F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma.

Yin G, Wang Z, Song Y, Li X, Chen Y, Zhu L, Su Q, Dai D, Xu W. Yin G, et al. Among authors: li x. Front Oncol. 2021 Jul 22;11:709137. doi: 10.3389/fonc.2021.709137. eCollection 2021. Front Oncol. 2021. PMID: 34367993 Free PMC article.

6

Corrigendum: Prediction of EGFR Mutation Status Based on ¹⁸F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma.

Yin G, Wang Z, Song Y, Li X, Chen Y, Zhu L, Su Q, Dai D, Xu W. Yin G, et al. Among authors: li x. Front Oncol. 2021 Sep 7;11:747316. doi: 10.3389/fonc.2021.747316. eCollection 2021. Front Oncol. 2021. PMID: 34557420 Free PMC article.

7

Molecular subtype classification of breast cancer using established radiomic signature models based on ¹⁸F-FDG PET/CT images.

Liu J, Bian H, Zhang Y, Gao Y, Yin G, Wang Z, Li X, Ma W, Xu W. Liu J, et al. Among authors: li x. Front Biosci (Landmark Ed). 2021 Aug 30;26(9):475-484. doi: 10.52586/4960. Front Biosci (Landmark Ed). 2021. PMID: 34590460 Free article.

8

Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.

Chen Y, Wang Z, Yin G, Sui C, Liu Z, Li X, Chen W. Chen Y, et al. Among authors: li x. Ann Nucl Med. 2022 Feb;36(2):172-182. doi: 10.1007/s12149-021-01688-3. Epub 2021 Oct 30. Ann Nucl Med. 2022. PMID: 34716873

9

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma.

Yu X, Wang Z, Chen Y, Yin G, Liu J, Chen W, Zhu L, Xu W, Li X. Yu X, et al. Among authors: li x. Front Genet. 2021 Oct 15;12:771830. doi: 10.3389/fgene.2021.771830. eCollection 2021. Front Genet. 2021. PMID: 34721552 Free PMC article.

10

Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.

Dai D, Li XF, Wang J, Liu JJ, Zhu YJ, Zhang Y, Wang Q, Xu WG. Dai D, et al. Int J Cancer. 2016 Feb 15;138(4):1003-12. doi: 10.1002/ijc.29832. Epub 2015 Sep 22. Int J Cancer. 2016. PMID: 26334931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,109 results

Search Page

Filters